Showing results (151-160 of 426) with videos related to
Sort By:
Pageof 43
Neurobiology of Disease|April 13, 2001
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neuronsA R White, R Guirguis, M W Brazier, et al.Nature Medicine|September 1, 1997
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptidesT Hartmann, S C Bieger, B Brühl, et al.The Journal of Biological Chemistry|March 29, 2001
Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunitsC C Curtain, F Ali, I Volitakis, et al.The Journal of Biological Chemistry|March 28, 1998
Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domainR D Moir, T Lynch, A I Bush, et al.Neuroreport|April 20, 1999
Early-onset Alzheimer's disease caused by a novel mutation at codon 219 of the presenilin-1 geneM J Smith, R J Gardner, M A Knight, et al.Journal of Neurochemistry|September 29, 1999
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126M F Jobling, L R Stewart, A R White, et al.Annals of Neurology|January 1, 1997
Collection and normal levels of the amyloid precursor protein in plasmaS Whyte, N Wilson, J Currie, et al.The Journal of Infectious Diseases|April 1, 1990
Entry of neurotropic arboviruses into the central nervous system: an in vitro study using mouse brain endotheliumB Dropulić, C L MastersThe Journal of Biological Chemistry|August 7, 1999
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletionR A Cherny, J T Legg, C A McLean, et al.Die Naturwissenschaften|September 8, 2001
Alzheimer's disease: molecular concepts and therapeutic targetsK Fassbender, C Masters, K BeyreutherPageof 43